DataKnowledgeCloudtrainingcoordination

COL Q07157-1 GLY 000517 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

ZO1 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

human proteoform glycosylation sites oglcnac mcw.csv

File (Entity type)

Description:Information for protein Q07157-1 in the context of file GLY_000517

Creation Time:2026-03-02 19:57:25.000000

Results found

Linked to

	Label	Description
	ZO1 HUMAN Protein (Entity type)	Tight junction protein ZO-1
	q07157-1 1366ser 1366ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 978ser 978ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 976thr 976thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 1071ser 1071ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 1425thr 1425thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 979thr 979thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 1493thr 1493thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 1443thr 1443thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q07157-1 366thr 366thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Protein

ZO1 HUMAN

Protein (Entity type)

Tight junction protein ZO-1

Post Translational Modification

q07157-1 1366ser 1366ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 978ser 978ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 976thr 976thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 1071ser 1071ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 1425thr 1425thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 979thr 979thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 1493thr 1493thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 1443thr 1443thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q07157-1 366thr 366thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.